drugset / Trial / NCT01228656
Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone Furoate
RandomizedParallel-groupDouble-blindTreatment
Summary
The aims is to evaluate the efficacy and comparative isolation of the association Mometasone furoate + Salicylic Acid and the substance isolated Mometasone furoate produced by the Laboratory Glenmark Pharmaceuticals Ltd. in patients of both sexes, patients with plaque psoriasis grade mild to moderate.
Timeline
- Start
- 2006-09
- Primary completion
- 2010-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mometasone furoate | Other / unclassified | 0.1 % | Topical |
| Subject | salicylic acid | Small molecule | 5 % | Topical |